Section Arrow
ZVRA.NASDAQ
- Zevra Therapeutics
Quotes are at least 15-min delayed:2026/04/23 08:26 EDT
Pre Market
Last
 10.42
-0.07 (-0.67%)
Bid
10.35
Ask
10.6
High 10.68 
Low 10.42 
Volume 3.13K 
Regular Hours (Closed)
Last
 10.49
+0.1 (+0.96%)
Day High 
10.77 
Prev. Close
10.39 
1-M High
10.95 
Volume 
803.57K 
Bid
10.35
Ask
10.6
Day Low
10.425 
Open
10.53 
1-M Low
8.71 
Market Cap 
614.20M 
Currency 美元 
P/E 7.7 
%Yield -- 
10-SMA 10.08 
20-SMA 9.7 
50-SMA 9.38 
52-W High 13.16 
52-W Low 7.11 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.35/1.33
Enterprise Value
676.99M
Balance Sheet
Book Value Per Share
2.62
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
106.47M
Operating Revenue Per Share
0.28
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.2224+0.0256+13.01%-- 
Pre Market 0.20745 -0.01495 -6.72%
TOVXTheriva Biologics Inc0.3731+0.0344+10.16%0.09PE
Pre Market 0.3441 -0.029 -7.77%
IOVAIovance Biotherapeutics3.53-0.17-4.59%-- 
Pre Market 3.47 -0.06 -1.70%
REPLReplimune Group2.27+0.41+22.04%-- 
Pre Market 2.28 +0.01 +0.44%
GERNGeron Corp1.55+0.05+3.33%-- 
Pre Market 1.5499 -0.0001 -0.01%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.